53,654 Shares in Agilent Technologies, Inc. $A Purchased by Osmosis Investment Management UK Ltd

Osmosis Investment Management UK Ltd acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 53,654 shares of the medical research company’s stock, valued at approximately $7,127,000.

Several other hedge funds have also recently bought and sold shares of A. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of Agilent Technologies by 4.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after purchasing an additional 24,687 shares during the last quarter. Bank of Nova Scotia bought a new stake in shares of Agilent Technologies during the 2nd quarter worth $58,539,000. Dudley & Shanley Inc. boosted its stake in Agilent Technologies by 25.9% in the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after buying an additional 14,300 shares in the last quarter. Crossmark Global Holdings Inc. boosted its stake in Agilent Technologies by 39.6% in the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock valued at $4,615,000 after buying an additional 9,615 shares in the last quarter. Finally, Capricorn Fund Managers Ltd bought a new position in Agilent Technologies in the first quarter valued at about $8,161,000.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $159.25 on Monday. The stock has a 50-day moving average price of $137.57 and a two-hundred day moving average price of $126.17. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.51. The company has a market capitalization of $44.98 billion, a PE ratio of 31.98, a P/E/G ratio of 2.80 and a beta of 1.25. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the previous year, the business posted $1.31 earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts expect that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Analysts Set New Price Targets

A has been the subject of several research analyst reports. TD Cowen boosted their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective for the company. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Finally, Piper Sandler assumed coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.24.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.